Pharmacology Biotech (02269) announced that it will issue 1.5 million shares at an issue price of HK$1.29 per share on November 8, 2023, in accordance with the initial public pre-sale share option plan adopted on January 5, 2016.
In addition, 93,500 shares were issued as a result of the exercise of the share options plan.